A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction

Stem Cell Research and Therapy

Volumn 3, Issue 5, 2012, Pages

  Flynn, Aidan ^a,b   Chen, Xizhe ^a   O'Connell, Enda ^a   O'Brien, Timothy ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac failure; cardiac repair; guiding; mesenchymal stem cell; myocardial infarction; pre conditioned; stem cell; umbilical cord; unrestricted somatic stem cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; CELL TRANSPLANTATION; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROARRAY ANALYSIS; MITOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; UNRESTRICTED SOMATIC STEM CELL TRANSPLANTATION; ACUTE DISEASE; ANIMAL; BONE MARROW; BONE MARROW CELL; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; STEM CELL;

RATTUS;

ACUTE DISEASE; ANIMALS; BONE MARROW; BONE MARROW CELLS; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 84868005318     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt127     Document Type: Article

References (33)

1. Paracrine mechanisms in adult stem cell signaling and therapy. Gnecchi M, Zhang Z, Ni A, Dzau VJ, Circ Res 2008 103 1204 1219 10.1161/CIRCRESAHA.108. 176826 19028920
2. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE, Circulation 2004 109 1543 1549 Erratum in Circulation 2005, 112: e73 10.1161/01.CIR.0000124062.31102.57 15023891 (Pubitemid 38420184)
3. Optimizing adult mesenchymal stem cells for heart repair. Behfar A, Terzic A, J Mol Cell Cardiol 2007 42 283 284 10.1016/j.yjmcc.2006.11.003 17174974 (Pubitemid 46156949)
4. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H, Circulation 2006 113 1287 1294 10.1161/CIRCULATIONAHA.105.575118 16520413 (Pubitemid 43739450)
5. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, Circulation 2002 105 93 98 10.1161/hc0102.101442 11772882 (Pubitemid 34049148)
6. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ, Ann Thorac Surg 2002 73 1919 1925 10.1016/S0003-4975(02)03517-8 12078791 (Pubitemid 34596742)
7. Allogenic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiation capacity. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM, Proc Natl Acad Sci USA 2009 106 14022 14027 10.1073/pnas.0903201106 19666564
8. Terminal differentiation is not a major determinant for the success of stem cell therapy-cross-talk between muscle-derived stem cells and host cells. Gharaibeh B, Lavasani M, Cummins JH, Huard J, Stem Cell Res Ther 2011 2 31 10.1186/scrt72 21745421
9. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508 (Pubitemid 40562318)
10. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A, J Am Coll Cardiol 2010 56 721 734 10.1016/j.jacc.2010.03.066 20723802
11. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. Kögler G, Sensken S, Airey JA, Trapp T, Müschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Müller HW, Zanjani E, Wernet P, J Exp Med 2004 200 123 135 10.1084/jem.20040440 15263023 (Pubitemid 38982172)
12. Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Iwasaki H, Kawamoto A, Willwerth C, Horii M, Oyamada A, Akimaru H, Shibata T, Hirai H, Suehiro S, Wnendt S, Fodor WL, Asahara T, Arterioscler Thromb Vasc Biol 2009 29 1830 1835 10.1161/ATVBAHA.109.192203 19679830
13. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S, Muhs A, Spitkovsky D, Li RK, Circulation 2005 112 96 I104 10.1161/ CIRCULATIONAHA.104.500256 16159872
14. Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependent. Winter M, Wang XN, Daubner W, Eyking A, Rae M, Dickinson AM, Wernet P, Kögler G, Sorg RV, J Cell Mol Med 2009 13 2465 2475 10.1111/j.1582-4934.2008.00566.x 19175687
15. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Huang da W, Sherman BT, Lempicki RA, Nature Protocols 2009 4 44 19131956
16. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Huang DW, Sherman BT, Lempicki RA, Nucleic Acids Res 2009 37 1 13 10.1093/nar/gkn923 19033363
17. Microarray Gene Expression Data Society. http://www.mged.org/Workgroups/ MIAME/miame.html
18. ArrayExpress Archive. http://www.ebi.ac.uk/microarray-as/ae/
19. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S, Nat Med 2001 7 430 436 10.1038/86498 11283669 (Pubitemid 32298545)
20. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar RR, Int J Cardiol 2006 111 231 239 10.1016/j.ijcard.2005.07.036 16246440
21. Cardiac stem cells in patients with ischemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P, Lancet 2011 378 1847 1857 10.1016/S0140-6736(11)61590-0 22088800
22. C-Cure multicenter trial: lineage specified bone marrow derived cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy. Bartunek J, Wijns W, Dolatabadi D, Vanderhayden M, Dens J, Ostojic M, Behfar A, Henry S, Tendera M, Waldman S, J Am Coll Cardiol 2011 57 200 10.1016/S0735-1097(11)60200-3
23. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, Zhang L, Pratt RE, Dzau VJ, Ingwall JS, Stem Cells 2009 27 971 979 10.1002/stem.12 19353525
24. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Prat-Vidal C, Roura S, Farré J, Gálvez C, Llach A, Molina CE, Hove-Madsen L, Garcia J, Cinca J, Bayes-Genis A, Transplant Proc 2007 39 2434 2437 10.1016/j.transproceed.2007.06.016 17889212 (Pubitemid 47418128)
25. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S, Cell Transplant 2011 20 655 667 10.3727/096368910X536473 21054940
26. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Lin CS, Lin G, Lue TF, Stem Cells Dev 2012
27. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M, Kaluzhny Y, Mazouz N, Willemsen P, Penicka M, Mathieu M, Homsy C, De Bruyne B, McEntee K, Lee IW, Heyndrickx GR, Am J Physiol Heart Circ Physiol 2007 292 1095 H1104 17056665
28. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH, Bae JW, Oh BH, Park YB, Kim HS, J Am Coll Cardiol 2008 51 933 943 10.1016/j.jacc.2007.11.040 18308163 (Pubitemid 351282455)
29. Gap junctions and the propagation of cell survival and cell death signals. Krysko DV, Leybaert L, Vandenabeele P, D'Herde K, Apoptosis 2005 10 459 469 10.1007/s10495-005-1875-2 15909108 (Pubitemid 40896652)
30. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI, Regul Pept 2004 117 3 10 10.1016/j.regpep.2003.09.005 14687695 (Pubitemid 37548393)
31. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL, Eur Heart J 2006 27 1114 1122 16510464
32. Structure and mechanics of healing myocardial infarcts. Holmes JW, Borg TK, Covell JW, Annu Rev Biomed Eng 2005 7 223 253 10.1146/annurev.bioeng.7. 060804.100453 16004571 (Pubitemid 41170188)
33. Intracoronary delivery of bone-marrow-derived stem cells. Bui QT, Gertz ZM, Wilensky RL, Stem Cell Res Ther 2010 1 29 10.1186/scrt29 20863415